Takeda’s OBLEAN Near-Certain to Debut as Japan’s 1st Anti-Obesity Drug in 20 Years

Takeda Pharmaceutical’s OBLEAN Tablets 120 mg (cetilistat) cleared a key health ministry committee last month, pending to become the first anti-obesity drug to win approval in Japan in some 20 years. It is the first time for the Japanese pharmaceutical...read more